MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer

BACKGROUND: In the absence of targetable mutations or immune checkpoints, cisplatin-doublet chemotherapy remains the standard of care in non-small cell lung cancer (NSCLC). Drug resistance has however become a significant clinical challenge. Exploring a role for small non-coding microRNAs (miRNA) as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Lung Cancer Res
Main Authors: MacDonagh, Lauren, Gallagher, Michael F., Ffrench, Brendan, Gasch, Claudia, Gray, Steven G., Reidy, Marie, Nicholson, Siobhan, Leonard, Niamh, Ryan, Ronan, Young, Vincent, O’Leary, John J., Cuffe, Sinead, Finn, Stephen P., O’Byrne, Kenneth J., Barr, Martin P.
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107736/
https://ncbi.nlm.nih.gov/pubmed/34012792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-959
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados